Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05171660. IPD Sharing: NO. Countries: 1. Publications: 1.
Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma
ClinicalTrials.gov study NCT01989585. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Trea
ClinicalTrials.gov study NCT05554328. IPD Sharing: YES. Countries: 2. Publications: 0.
iMagemHTT: FIH Evaluation of Novel Mutant Huntingtin PET Radioligands [¹¹C]CHDI-00485180-R and [¹¹C]CHDI-00485626
ClinicalTrials.gov study NCT03810898. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations
ClinicalTrials.gov study NCT02278133. IPD Sharing: Not stated. Countries: 10. Publications: 2.
Pemetrexed vs Pemetrexed Plus Cisplatin in EGFR-mutant NSCLC Patients After First Line EGFR-TKIs Failure
ClinicalTrials.gov study NCT02725918. IPD Sharing: NO. Countries: 1. Publications: 4.
Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.
ClinicalTrials.gov study NCT03994393. IPD Sharing: Not stated. Countries: 2. Publications: 1.
a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors
ClinicalTrials.gov study NCT06166836. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer
ClinicalTrials.gov study NCT04965818. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01437618. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas
ClinicalTrials.gov study NCT01748149. IPD Sharing: NO. Countries: 2. Publications: 1.
Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study
ClinicalTrials.gov study NCT02145143. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid
ClinicalTrials.gov study NCT01340833. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma
ClinicalTrials.gov study NCT02125240. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation
ClinicalTrials.gov study NCT07094464. IPD Sharing: NO. Countries: 1. Publications: 10.
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
ClinicalTrials.gov study NCT06616636. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited Metastases
ClinicalTrials.gov study NCT01972490. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
ClinicalTrials.gov study NCT05462717. IPD Sharing: NO. Countries: 13. Publications: 1.
Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501）
ClinicalTrials.gov study NCT06924398. IPD Sharing: NO. Countries: 1. Publications: 6.
A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy
ClinicalTrials.gov study NCT05338619. IPD Sharing: NO. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.